Referred to the Committee on Energy and Commerce, and in addition to the Committees on Ways and Means, and Education and Workforce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Summary
HR 10227, the INSULIN Act of 2026, has been referred to the Energy and Commerce Committee and also to the Ways and Means and Education and Workforce committees for further review. The measure is intended to address matters related to insulin, though the specific provisions have not been detailed in the available synopsis. It is currently awaiting committee action.
AI-generated summary — may be incomplete or inaccurate. Verify against the official bill text.
Topics
Track this bill
Get real-time alerts when HR 10227 changes status, plus AI-powered summaries and stage predictions.
Sign up free